Cargando…

Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial

This study assessed the potential advantages of treating hepatorenal syndrome-acute kidney injury (HRS-AKI) with terlipressin versus placebo in the ICU setting. DESIGN: Patients were randomly assigned in a 2:1 ratio to receive terlipressin or placebo for up to 14 days. SETTING: A retrospective analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karvellas, Constantine J., Subramanian, Ram, Olson, Jody C., Jamil, Khurram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060094/ https://www.ncbi.nlm.nih.gov/pubmed/37007903 http://dx.doi.org/10.1097/CCE.0000000000000890

Ejemplares similares

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
por: Velez, Juan Carlos Q., et al.
Publicado: (2023)

Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome
por: Moore, Kevin, et al.
Publicado: (2020)

Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies
por: Curry, Michael P., et al.
Publicado: (2023)

The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin
por: Flamm, Steven L., et al.
Publicado: (2021)

Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure
por: Wong, Florence, et al.
Publicado: (2022)

Hepatorenal syndrome:Response to terlipressin and albumin and its determinants
por: Sarwar, Shahid, et al.
Publicado: (2016)

Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT
por: Belcher, Justin M.
Publicado: (2023)

An investigation of reconstituted terlipressin infusion stability for use in hepatorenal syndrome
por: Bui, Thi Ngoc Nhieu, et al.
Publicado: (2020)

In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample
por: Kaewput, Wisit, et al.
Publicado: (2021)

Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function
por: Huang, Xingyue, et al.
Publicado: (2023)

Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis
por: Wang, Haiqing, et al.
Publicado: (2018)

Clinical Characteristics, Management, and Outcomes of Cancer Patients With Coronavirus Disease 2019 Admitted to the ICU
por: Dang, Michael K. M., et al.
Publicado: (2021)

Characteristics and Outcomes for Low-Risk Hospital Admissions Admitted to the ICU: A Multisite Cohort Study
por: Prager, Ross T., et al.
Publicado: (2021)

Early Bacterial Coinfections in Patients Admitted to the ICU With COVID-19 or Influenza: A Retrospective Cohort Study
por: Bergmann, Felix, et al.
Publicado: (2023)

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
por: Kim, Hae Rim, et al.
Publicado: (2013)

Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome
por: Chiang, Chi-Wen, et al.
Publicado: (2019)

Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
por: Mohamed, Mohamed M G, et al.
Publicado: (2021)

Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
por: Ayyad, Ahlam, et al.
Publicado: (2023)

Relationship Between Skeletal Muscle Quality and Hospital-Acquired Disability in Patients With Sepsis Admitted to the ICU: A Pilot Study
por: Takahashi, Yuta, et al.
Publicado: (2023)

Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: A meta-analysis
por: Hiremath, Sharanabasayyaswamy B., et al.
Publicado: (2013)

Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
por: Nassar Junior, Antonio Paulo, et al.
Publicado: (2014)

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?
por: Altun, Reskan, et al.
Publicado: (2015)

Association Between Acute Kidney Injury During Invasive Mechanical Ventilation and ICU Outcomes and Respiratory System Mechanics
por: Vemuri, Sneha V., et al.
Publicado: (2022)

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
por: Bai, Zhaohui, et al.
Publicado: (2020)

Multistate Modeling of Clinical Trajectories and Outcomes in the ICU: A Proof-of-Concept Evaluation of Acute Kidney Injury Among Critically Ill Patients With COVID-19
por: Lyons, Patrick G., et al.
Publicado: (2022)

Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome
por: Wong, Florence, et al.
Publicado: (2019)

Child Opportunity Index and Hospital Utilization in Children With Traumatic Brain Injury Admitted to the PICU
por: Gray, Monica M., et al.
Publicado: (2023)

Advanced Respiratory Support in the Contemporary Cardiac ICU
por: Metkus, Thomas S., et al.
Publicado: (2020)

Multicenter Retrospective Review of Ketamine Use in the ICU
por: Groth, Christine M., et al.
Publicado: (2022)

Terlipressin-Induced Skin Necrosis While Managing Hepatorenal Syndrome: A Rare Case Report From North India
por: Sudan, Sourav, et al.
Publicado: (2023)

Low ICU Burnout in a Safety Net Hospital
por: LeClaire, Michele M., et al.
Publicado: (2019)

Screening for Social Risk Factors in the ICU During the Pandemic
por: Ge, Derek, et al.
Publicado: (2022)

Practical Strategies Related to the Application of Balloon Tamponade Therapy in Acute Variceal Bleeding
por: Bari, Vase, et al.
Publicado: (2022)

In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V(1) and V(2)
por: Jamil, Khurram, et al.
Publicado: (2017)

Association Between ICU-Acquired Hypernatremia and In-Hospital Mortality: Data From the Medical Information Mart for Intensive Care III and the Electronic ICU Collaborative Research Database
por: Olsen, Markus Harboe, et al.
Publicado: (2020)

Impact of Fellows-as-Teachers Workshops on Teaching Rounds: An Observational Study in an ICU
por: Bergl, Paul A., et al.
Publicado: (2020)

A Simplified Electroencephalography Montage and Interpretation for Evaluation of Comatose Patients in the ICU
por: Abid, Sonia, et al.
Publicado: (2022)

A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug
por: Thangaraj, Santhosh Raja, et al.
Publicado: (2023)

The Hepatorenal Syndrome Patient Pathway: Retrospective Analysis of Electronic Health Records
por: Jamil, Khurram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c909dc5goo5l06qsq1b8qp2u9r